Substantial evidence from a few studies suggested that the alteration of normal FHIT function could be an important event in the pathogenesis of many human hematological malignancies including ALL and the altered FHIT gene expression is specifically identified factor and highly persistent event in leukemia [21, 41]. This evidence concerns the gene FHIT and leukemia.